156 related articles for article (PubMed ID: 9607850)
41. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
Okwor I; Jia P; Uzonna JE
J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
[TBL] [Abstract][Full Text] [Related]
42. Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.
Maspi N; Ghaffarifar F; Sharifi Z; Dalimi A
Parasite Immunol; 2016 Apr; 38(4):228-35. PubMed ID: 26868280
[TBL] [Abstract][Full Text] [Related]
43. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection.
Gonzalez-Lombana C; Gimblet C; Bacellar O; Oliveira WW; Passos S; Carvalho LP; Goldschmidt M; Carvalho EM; Scott P
PLoS Pathog; 2013 Mar; 9(3):e1003243. PubMed ID: 23555256
[TBL] [Abstract][Full Text] [Related]
44. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
45. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
Erb KJ; Blank C; Moll H
Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
[TBL] [Abstract][Full Text] [Related]
46. Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4.
Ritter U; Moll H
Eur J Immunol; 2000 Nov; 30(11):3111-20. PubMed ID: 11093125
[TBL] [Abstract][Full Text] [Related]
47. Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice.
Hezarjaribi HZ; Ghaffarifar F; Dalimi A; Sharifi Z; Jorjani O
Exp Parasitol; 2013 Jul; 134(3):341-8. PubMed ID: 23541883
[TBL] [Abstract][Full Text] [Related]
48. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
Shankar AH; Morin P; Titus RG
Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
[TBL] [Abstract][Full Text] [Related]
49. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
Noben-Trauth N; Paul WE; Sacks DL
J Immunol; 1999 May; 162(10):6132-40. PubMed ID: 10229856
[TBL] [Abstract][Full Text] [Related]
50. IFN-gamma produced in vivo during the first two days is critical for resolution of murine Leishmania major infections.
Leiby DA; Schreiber RD; Nacy CA
Microb Pathog; 1993 Jun; 14(6):495-500. PubMed ID: 8412622
[TBL] [Abstract][Full Text] [Related]
51. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
52. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
[TBL] [Abstract][Full Text] [Related]
53. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.
Wershil BK; Theodos CM; Galli SJ; Titus RG
J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970
[TBL] [Abstract][Full Text] [Related]
54. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
55. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis.
Bomfim G; Nascimento C; Costa J; Carvalho EM; Barral-Netto M; Barral A
Exp Parasitol; 1996 Nov; 84(2):188-94. PubMed ID: 8932768
[TBL] [Abstract][Full Text] [Related]
56. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
Mocci S; Coffman RL
J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
[TBL] [Abstract][Full Text] [Related]
57. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
Morris L; Troutt AB; Handman E; Kelso A
J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029
[TBL] [Abstract][Full Text] [Related]
58. In situ cytokines (IL-4, IL-10, IL-12, IFN-γ) and chemokines (MCP-1, MIP-1α) gene expression in human Leishmania (Leishmania) Mexicana infection.
Valencia-Pacheco G; Loría-Cervera EN; Sosa-Bibiano EI; Canché-Pool EB; Vargas-Gonzalez A; Melby PC; Andrade-Narvaez FJ
Cytokine; 2014 Sep; 69(1):56-61. PubMed ID: 25022962
[TBL] [Abstract][Full Text] [Related]
59. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
[TBL] [Abstract][Full Text] [Related]
60. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
Alleva DG; Kaser SB; Beller DI
J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
